Artrya Limited (ASX: AYA) - ETF Exposure
Current share price for AYA : $3.190 0.25 (7.27%)+
Artrya Limited (AYA) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is a company engaged in the development and commercialisation of a patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease.
AYA General Information +
| ASX Code | AYA |
| Website | N/A |
| Industry/Sector | Health Care Technology |
| Market Cap ($M) | 521 |
| AYA Share Price | $3.190 |
| Day High | $3.765 |
| Day Low | $3.150 |
| Last Close | $3.440 |
| AYA Share Price Movement | $0.25 ( 7.27% ) |
Prices as at 16:40, 13 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Already own an Australian ETF? You may already have meaningful exposure to AYA
Artrya Limited (AYA) is held across 5 ETFs spanning strategies that include health care technology exposure . Its weighting in those funds means performance can have an outsized influence - when AYA moves, funds like M1DS, ATEC, ISO, SSO and VAS that hold it can move with it.
For more concentrated exposure, ETFs such as M1DS (Paradice Australian Mid Cap Fund Active ETF) allocate about 0.5% to AYA , while the average exposure across all 5 ETFs that hold it is around 0.3% .
Top ETF holdings
- Paradice Australian Mid Cap Fund Active ETF (M1DS) ~ 0.5%
- BetaShares S&P/ASX Australian Technology ETF (ATEC) ~ 0.5%
- iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO) ~ 0.2%
- State Street SPDR S&P/ASX Small Ordinaries ETF (SSO) ~ 0.2%
- Vanguard Australian Shares Index ETF (VAS) ~ 0%
Last updated: ETF data and holdings as at 13 November 2026
Own AYA directly or through an ETF?
How does holding Artrya Limited (AYA) shares directly compare to ETFs that include it?
|
AYA Direct
|
M1DS
CBOE |
ATEC
ASX |
ISO
ASX |
SSO
ASX |
VAS
ASX |
|
|---|---|---|---|---|---|---|
| Holdings | 1 company | 62 holdings | 51 holdings | 220 holdings | 220 holdings | 334 holdings |
| AYA Weight | 100% | 0.5% | 0.5% | 0.2% | 0.2% | 0% |
| Diversification | Single Stock | Broad | Broad | Broad | Broad | Broad |
| Annual Cost | Brokerage only | - | 0.48% p.a. | 0.55% p.a. | 0.5% p.a. | 0.07% p.a. |
| Approx. Yield | 0% | - | 1.78% | 4.52% | 9.62% | 3.06% |
| Star Ratings | - |  |
|
|
|
|
Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not AYA's direct yield. Annual cost uses each ETF's MER.
AYA Exposure on $10,000 investment
How a $10,000 investment in Artrya Limited (AYA) one week ago compares with ETFs that hold it.
| Security | Investment type | Current price | 7-day price movement | Dollar change | Value today |
|---|---|---|---|---|---|
| Artrya Limited (AYA) | Direct share | $3.190 | -8.86% | -$886 | $9,114 |
| Paradice Australian Mid Cap Fund Active ETF (M1DS) | Equity - Australia Strategy | $6.250 | 0.48% | +$48 | $10,048 |
| BetaShares S&P/ASX Australian Technology ETF (ATEC) | Equity - Australia Sectors | $23.130 | 1.58% | +$158 | $10,158 |
| iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO) | Equity - Australia Small/Mid Cap | $4.840 | 1.47% | +$147 | $10,147 |
| State Street SPDR S&P/ASX Small Ordinaries ETF (SSO) | Equity - Australia Small/Mid Cap | $13.950 | 1.23% | +$123 | $10,123 |
| Vanguard Australian Shares Index ETF (VAS) | Equity - Australia | $112.570 | 0.90% | +$90 | $10,090 |
Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.
Artrya Limited (AYA) ETFs
5 ETFs hold Artrya Limited (AYA).
| ETF | AYA Weight | MER | Yield |
|---|---|---|---|
| Paradice Australian Mid Cap Fund Active ETF (M1DS) | 0.5% | - | - |
| BetaShares S&P/ASX Australian Technology ETF (ATEC) | 0.5% | 0.48% | 1.78% |
| iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO) | 0.2% | 0.55% | 4.52% |
| State Street SPDR S&P/ASX Small Ordinaries ETF (SSO) | 0.2% | 0.5% | 9.62% |
| Vanguard Australian Shares Index ETF (VAS) | 0% | 0.07% | 3.06% |
Artrya Limited (AYA) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Artrya Limited (AYA) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Artrya Limited (AYA) price-sensitive announcements
AYA - Five Yr Agreement with HonorHealth Expands US Momentum
Artrya Limited announced a five-year commercial agreement with Arizona-based health system
Artrya Limited (AYA)
13 Nov 2026 | 8:50 AM
13 Nov 2026 | 8:50 AM
AYA - September Quarterly Activities Report and Appendix 4C
Artrya Limited’s September 2026 quarterly activities report and Appendix 4C outlined conti
Artrya Limited (AYA)
26 Oct 2026 | 8:40 AM
26 Oct 2026 | 8:40 AM
AYA - Huntsville Hospital Health System Commercial Agreement
Artrya Limited announced that Huntsville Hospital Health System (HH Health) has signed a f
Artrya Limited (AYA)
2 Oct 2026 | 8:32 AM
2 Oct 2026 | 8:32 AM
AYA - S&P DJI Announces September 2026 Quarterly Rebalance
S&P Dow Jones Indices announced on 4 September 2026 the September 2026 quarterly rebalance
Artrya Limited (AYA)
4 Sep 2026 | 5:10 PM
4 Sep 2026 | 5:10 PM
Artrya Limited (AYA) Recent ASX Announcements
AYA Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2028F | C2 | -$11.00 | -15.40% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2027F | C2 | -$13.00 | -23.40% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2026A | -$25.18 | -$17.00 | -4.50% | 0.00 | 0.00 | 0.00% | 0.0% |
AYA Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 A | 2027 F | 2028 F | 2026 A | 2027 F | 2028 F | 2026 A | 2027 F | 2028 F | ||
| 4DMedical Limited (4DX) | $1,391M | 1.7823 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Artrya Limited (AYA) | $563M | -0.0450 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Pro Medicus Limited (PME) | $21,185M | 1.3034 | -0.2811 | 0.2395 | 79.9645 | 111.2336 | 89.7380 | 0.34% | 0.46% | 0.57% |
AYA Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Bernard (Bernie) William Ridgeway | Non-Executive Chairman, Non-Executive Director | 8 Feb 2021 |
| Ms Helen Kurincic | Non-Executive Director | 20 Aug 2026 |
| Dr Jacque Sokolov | Non-Executive Director | 1 Aug 2022 |
| Ms Catherine (Kate) Hill | Non-Executive Director | 22 Feb 2023 |
| Dr Jeffrey LeBenger | Non-Executive Director | 18 Feb 2026 |
Artrya Limited (AYA) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 18 Jun 2026 | RIDGEWAY, Bernard (Bernie) | Exercise | Options | 750,000 | $1.000 | $750,000.000 |
| 18 Jun 2026 | RIDGEWAY, Bernard (Bernie) | Buy | Indirect Shares | 750,000 | $1.000 | $750,000.000 |
| 11 Jun 2026 | RIDGEWAY, Bernard (Bernie) | Sell | Indirect Shares | 300,000 | $4.600 | $1,380,000.000 |
See all changes in directors' interest & trades for Artrya Limited (AYA) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
AYA Management
| Name | Position |
|---|---|
| Ioannis (John) Konstantopoulos | Co-Founder,Chief Executive Officer |
| Mark Edward Pitts | Company Secretary |
AYA Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Artrya Limited (AYA). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 17,483,419 (11.06%) | Regal Funds Management Pty Limited |
| 10,626,240 (6.72%) | Wilson Asset Management Group |
| 8,212,647 (5.04%) | UBS Group AG |
| 7,905,758 (5%) | David Paradice |
AYA Calendar of Events
| Date | Event |
|---|---|
| 31 August 2027 | Report (Prelim) |
| 18 August 2027 | Report (Annual) |
| 18 August 2027 | Report (Prelim) |
| 24 February 2027 | Report (Interim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
